New Report Available: C2N Diagnostics LLC - Product Pipeline Analysis, 2013 Update
C2N Diagnostics LLC (C2N Diagnostics) is a biotechnology service provider. The company develops tools and assays for clinical drug development, pre-clinical drug discovery and the early detection and assessment of neurodegenerative disorders. It offers products that include SILK-Ab and SISAQ-Ab Assays. The company's products utilize stable isotope labeling and tandem mass spectrometry for the measurement of the kinetics, or in vivo metabolism, and absolute quantitation of brain derived proteins. It also develops products to treat Huntington's disease, Parkinson's disease, brain...
View full press release